6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
5G122

SMB Laboratories SA

About SMB Laboratories SA

S.M.B., a Belgian based pharmaceutical company with global ambitions, has used its 50-years experience, know-how and state of the art technologies to identify and develop its own Drug Delivery Systems designed for selected active ingredients to improve patients’ outcomes. S.M.B. proposes a portfolio of products in Respiratory tract, Cardiovascular system,pain management and OTC.

Meet us at

  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    Belgium
  • On CPHI since:
    2015
Company types
Manufacturer/Innovator
Contact info

Products from SMB Laboratories SA (25)

  • Apixaban 2.5 mg & 5mg

    Product Apixaban 2.5 mg & 5mg

    Unique formulation based on pellets Added value generic BA/BE CTD dossier
  • Cholecalciferol 7200IU/ml drops

    Product Cholecalciferol 7200IU/ml drops

    Oral solution Increased concentration for faster administration CTD dossier
  • Paracetamol + Ibuprofen 500mg/200mg Fixed Dose Combination

    Product Paracetamol + Ibuprofen 500mg/200mg Fixed Dose Combination

    For the treatment of moderate pain Coated tablets CTD format
  • Rosuvastatin + fenofibrate 20mg/160mg & 10mg/160mg Fixed dose combination

    Product Rosuvastatin + fenofibrate 20mg/160mg & 10mg/160mg Fixed dose combination

    based on proprietary Lidose technology for the treatement of mixed dyslipidemia CTD dossier
  • Tiotropium 7µg dry powder for inhalation

    Product Tiotropium 7µg dry powder for inhalation

    For the treament of COPD Hybride product- added value generic CTD dossier
  • Budesonide+Salmeterol DPI - 240/20µg or 120/20µg FDC

    Product Budesonide+Salmeterol DPI - 240/20µg or 120/20µg FDC

    Intro

    Dossier:
    Indication:
    Formulation:


     Innovative Fixed Dose Combination of Budesonide and Salmeterol at in two dosages : 240/20µg and 120/20µg (delivered dose) as dry powder for inhalation.Dossier : CTD
    Indication: Regular treatment of asthma where use of a combination (i...
  • Buprenorphine 2 mg, 8 mg sublingual tablets

    Product Buprenorphine 2 mg, 8 mg sublingual tablets

    Intro

    Dossier: 
    Indication: 
    Formulation: 


  • Cholecacliferol+calcium 1000IU/1000mg FDC

    Product Cholecacliferol+calcium 1000IU/1000mg FDC

    Intro

    Dossier:
    Indication:
    Formulation:

    SMB Laboratories S.A. offer a wide range of products which includes chlorhexidinl cholecacliferol+calcium (vit. D+Ca) (OTC). It belongs to vitamins category. Indication: Food supplement. Formulation: Chewable tablets. Packaging: packs of 1...
  • Cholecalciferol Capsules 5600IU; 125000IU; 25000IU

    Product Cholecalciferol Capsules 5600IU; 125000IU; 25000IU

    Intro

    Dossier:
    Indication:
    Formulation:

    Innovative cholecalciferol in sealed hard caspules witha dosage of either 5600IU; 12500IU or 25000IU per capsulesDossier : CTD
    Indication: Treatment of vitamin D deficiency, initial treatment of vitamin D deficiency, vitamin D deficie...
  • Cholecalciferol Drops 2400IU/ml; 7200IUml

    Product Cholecalciferol Drops 2400IU/ml; 7200IUml

    Intro

    Dossier:
    Indication:
    Formulation:

    Drops of choelcalciferol as oily solution in glass bottles at eitehr 2400IU/ml or 72000IU/ml Dossier : CTD (2400IU/ml); Food Supplement (7200IU/ml)
    Indication: Prophylaxis of a vitamin D deficiency disease, supportive treatment o...

SMB Laboratories SA Resources (1)